OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Thrombosis and Hemostasis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
	70
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	43
	43
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	38
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	33
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	32
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	30
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	30
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	30
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	30
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	29
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	29
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment	28
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	28
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	28
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	28
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	27
Platelet Function Testing: Update and Future Directions	26
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	26
Testing for Lupus Anticoagulants	24
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	24
Fifty Years of Fibrinogen Structure and Function	21
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	21
Application of ACR/EULAR Classification Criteria in real life: thrombotic patients positive for Lupus Anticoagulant only	21
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	21

Platelet Activation and Thrombosis in COVID-19	21
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review	20
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	19
Editorial Compilation—XIII	19
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	19
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	17
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice	17
The History of Rare Bleeding Disorders	17
Toward 50 Years of Seminars in Thrombosis and Hemostasis	16
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	16
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism	16
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future	16
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	15
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	14
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	14
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase	14
	14
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?	14
Bleeding in patients with renal impairment – a current perspective	14
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	14
	14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management	14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	13
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	13
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans	13
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale	13
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	12
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data	12
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency	12
	12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	12
Automation in Platelet Function Testing: Current Challenges and Future Directions	12
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis	12
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer	12
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	12
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review	12
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic	12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls	11
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection	11
A Historical Perspective on the Reversal of Anticoagulants	11
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	11
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives	11
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	11
Venous Thromboembolism in Children: The Rivaroxaban Experience	11
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	11
Editorial Compilation XIV	11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities	11
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis	11

Colchicine as a Modulator of Platelet Function: A Systematic Review	11
Bleeding Scoring Systems in Neonates: A Systematic Review	11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia	10
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	10
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	10
	10
Editorial Compilation XI	10
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis	10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	10
Precision Medicine in Rare Bleeding Disorders	10
Thrombin Generation Assays: What are the Current Clinical Applications?	10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions	10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	10
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	10
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass	9
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?	9
The Role of Platelets in Atherosclerosis: A Historical Review	9
	9
Hemostasis Testing in the Emergency Department: A Narrative Review	9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	9
Do we Have the Gut to Beat Thrombosis?	9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	9
Non-factor Therapies for Hemophilia: Achievements and Perspectives	9
Platelet Physiology	9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	9
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	9
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	8
	8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality	8
NETosis in Acute Thrombotic Disorders	8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?	8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond	8
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment	8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction	8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives	8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care	8
Evolution of Antiphospholipid Syndrome	7
	7
Next-Generation Sequencing and Emerging Technologies*	7
Internal Quality Control in Hemostasis Assays	7
One Hundred Years of Congenital Fibrinogen Disorders	7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	7
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets	7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up	7
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke	7
Crucial Stepping Stones in Platelet History	7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies	7
	7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	7
The More Recent History of Hemophilia Treatment	7
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?	7
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research	6
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study	6
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency	6
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	6
Welcome to Seminars in Thrombosis & Hemostasis 2022	6
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	6
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen	6
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review	6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	6
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial	6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation	6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer	6
Clinical, Laboratory Aspects and Management of Factor X Deficiency	6
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients	6
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	6
	5
Red Blood Cells and Tranexamic Acid in the Inhibition of Fibrinolysis	5
A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity	5
Plasma Kallikrein as a Forgotten Clotting Factor	5
Platelets in Neonatal Sepsis: Beyond Clotting, from Silent Players to Immune Orchestrators	5
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome	5
Unlocking the Potential of MicroRNA Expression: Biomarkers for Platelet Reactivity and Coronary Artery Disease	5

Congenital Bleeding Disorders and COVID-19—A Systematic Literature Review	5
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	5
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	5
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges	5
Impact of Viral Infections on the Hemostatic System	5
Monitoring Hemostatic Function during Cardiac Surgery with Point-of-Care Viscoelastic Assays: A Narrative Review	5
Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors	5
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes	5
What Role Does Microthrombosis Play in Long COVID?	5
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	5
Thrombosis Risk Assessment in Myeloproliferative Neoplasm—Is There a Role for Viscoelastic Testing?	5
Platelet Function in Acute Kidney Injury: A Systematic Review and a Cohort Study	5
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	5
Laboratory Evaluation of Antithrombin, Protein C, and Protein S	5
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience	5
Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature	5
2023 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards	5
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	4
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	4
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	4
A Critical Reappraisal of the Bleeding Time	4
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	4
Editorial Compilation XII	4
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	4
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications	4
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	4
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	4
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis	4
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	4
PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease	4
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	4
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	4
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	4
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	4
Editorial Compilation—XV	4
Neutrophil-Mediated Effects on Hemostasis and Thrombosis: Unraveling Their Complex Interaction in Thrombotic Events	4
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	4
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	4
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	4
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality	4
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	4
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	4
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	4
Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease: Comment on “Cancers in Patients with von Willebrand Disease”	4
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	4
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	4
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	4
Platelets: Physiology and Biochemistry	4
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	4
Hemostasis, Thrombosis, and Vascular Biology in Psychiatric Disorders	4
	3
Flow Cytometric Assessment of Changes in Platelet Reactivity after Acute Coronary Syndrome: A Systematic Review	3
Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies	3
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	3
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	3
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	3
Optimizing and Extending the Risk-Adapted Management of Acute Pulmonary Embolism beyond the Acute Phase: Progress in Pulmonary Embolism Research	3
The Bleeding Time Test in 2024: A Glorious Past and Current Challenges	3
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment	3
Emicizumab in Acquired Hemophilia A: Benefits in Bleed Control, Safety, and Cost-Effectiveness	3
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study	3
Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report	3
Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)—A Systematic Review	3
	3
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	3
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male	3
	3
Antiphospholipid Antibodies in Mental Disorders	3
	3
Clinical Significance of Vascular Occlusive Events following Moderate-to-Severe Traumatic Brain Injury: An Observational Cohort Study	3
Tranexamic Acid: An Evergreen Hemostatic Agent	3
Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)	3
Prediction of Recurrent Venous Thromboembolism and Arterial Cardiovascular Events after Discontinuation of Anticoagulation: The R-VTE-predict and MACE-predict Risk Scores	3
Hereditary Angioedema and Venous Thromboembolism: Where There's Smoke, There's Fire	3
The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium	3
Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure	3
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort Study	3
Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study	3
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	3
Red Blood Cells are Critical for Hemostasis and Thrombosis	3
Prophylaxis of Venous Thromboembolism in Children: A Systematic Review	3
	3
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians	3
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	3
Measurement Uncertainty in the Haemostasis laboratory	3
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	3
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies	3
Erratum: Septic Pulmonary Embolism. A Contemporary Profile	2
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	2
ABO Blood Group and the Risk of Thrombosis in Cancer Patients: A Mini-Review	2
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	2